In recent years, the global pharmaceutical market, especially in China, has been booming. From 2015 to 2019, the compound annual growth rates of the global and Chinese pharmaceutical markets reached 4.6% and 7.5%, respectively. The urinary system and reproductive system are important systems responsible for human excretion and offspring reproduction. The global market size of urological and genitourinary cancers has continued to grow, with a compound annual growth rate of 15.3% during the period from 2015 to 2019, and it is expected to continue to expand rapidly in the future. Currently, therapies for urological and genitourinary diseases include surgeries that have serious adverse reactions and lead to a significant decline in patient quality of life, creating potential unmet clinical needs. Overall, with the advancement in understanding of urological and genitourinary diseases, small molecule targeted drugs targeting innovative targets and treatment methods for urological and genitourinary diseases based on innovative mechanisms have emerged, which can compensate for the shortcomings of existing medication regimens. In addition, basic research on urological and genitourinary diseases is also ongoing. Deeper research on diseases helps in developing safe and efficient drugs and also drives the rapid development of the urological and genitourinary disease drug market.
The above content is only a report summary. If you need to view more, please contact us. Thank you!
